UNSPSC 51112524: Trichlormethine

This classification denotes a nitrogen mustard compound with the molecular formula C6H12Cl3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66WBM7N0NM, chemically known as 2,2, 2-trichlorotriethylamine hydrochloride but more generally known as trichlormethine, which bears US NIH Compound Identifier 5561. European Medicines Agency schedules Trichlormethine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11264MIG.

UNSPSC 51112524 Trichlormethine is a Commodity code covering a chemotherapy agent used in cancer treatment protocols, but the code shows no recent state and local procurement activity. State and local governments do not typically procure individual pharmaceutical agents through their purchasing offices; acquisition occurs through hospital systems, health departments with dedicated pharmaceutical procurement channels, group purchasing organizations, or federal supply contracts. Without recent opportunities in the state and local market to ground the analysis, no issuing-body mix, geographic concentration, or representative solicitations can be identified from current activity.

The code's absence from recent state and local postings reflects the structure of pharmaceutical procurement in the public sector — even state health departments and county hospitals source chemotherapy drugs through specialized pharmaceutical vendors, GPO agreements, or the federal supply schedule rather than through general-market competitive solicitations. Firms pursuing state and local pharmaceutical sales should focus on the broader UNSPSC families covering pharmaceutical distribution, hospital supply contracts, and group purchasing arrangements rather than individual drug commodity codes.